Mitchell & Pahl Private Wealth, LLC Gsk PLC Transaction History

Mitchell & Pahl Private Wealth, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$42.05 - $47.77 $48,483 - $55,078	-1,153 Reduced 13.64%	7,298 $318,000
Q1 2022 Apr 14, 2022	SELL	$40.23 - $47.74 $23,011 - $27,307	-572 Reduced 6.34%	8,451 $368,000
Q4 2021 Jan 19, 2022	BUY	$38.88 - $45.31 $116 - $135	3 Added 0.03%	9,023 $398,000
Q3 2021 Nov 03, 2021	SELL	$38.79 - $43.16 $4,460 - $4,963	-115 Reduced 1.26%	9,020 $345,000
Q2 2021 Jul 14, 2021	SELL	$36.52 - $41.46 $5,112 - $5,804	-140 Reduced 1.51%	9,135 $364,000
Q1 2021 Apr 29, 2021	SELL	$34.27 - $40.01 $7,299 - $8,522	-213 Reduced 2.24%	9,275 $331,000
Q4 2020 Feb 09, 2021	BUY	$34.07 - $39.94 $323,256 - $378,950	9,488 New	9,488 $349,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Mitchell & Pahl Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Mitchell & Pahl Private Wealth, LLC with notifications on news.